Rituximab for the treatment of acute onset Interstitial Lung Disease in primary Sjogren's syndrome

Pulmonology. 2021 Nov-Dec;27(6):575-578. doi: 10.1016/j.pulmoe.2021.06.004. Epub 2021 Jul 10.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Humans
  • Lung
  • Lung Diseases, Interstitial* / drug therapy
  • Male
  • Middle Aged
  • Rituximab / therapeutic use
  • Sjogren's Syndrome* / complications
  • Sjogren's Syndrome* / drug therapy

Substances

  • Rituximab